- Who we are
- Wellness & Prevention
- Warrior
- Uncategorized
- Twitter Chats
- Triple Negative Breast Cancer
- Toolkit
- Tiger Talk Blog Series
- The Fearless Warrior Project
- Survivorship
- Stories
- Spirituality
- SABCS 2023
- SABCS
- Reflections
- Publications
- Programs
- Press Release
- Pledge Partner
- Nutrition
- Newsletter
- My Life
- MY LIFE
- Mindful Moments
- Metastatic Breast Cancer
- Metastatic Breast Cancer
- Love Your Bones
- Living with MBC
- Healthy Lifestyle
- Education
- Clincial Trials
- CLEART
- children
- Breast Cancer Toolkit
- Breast Cancer 101
- bone health
- Blog
- ANGEL Advocate
- All
What Cancer Taught Me: Advice from a Survivor
By Caitlin M. Kiernan There is no question that a cancer diagnosis is life-altering. I was never the same girl after my diagnosis. When I was first diagnosed with breast […]
Feinstein, Heller Introduce Bill to Improve Breast Cancer Detection
Legislation empowers women to make informed health care decisions Washington—Senators Dianne Feinstein (D-Calif.) and Dean Heller (R-Nev.) today introduced the Breast Density and Mammography Reporting Act of 2017, which would improve […]
October Newsletter
We are all too familiar with the publicity and promotion of Breast Cancer Awareness month. Together, let’s take it a step further! Our generous partners have joined us by hosting events and fundraisers throughout October to […]
3 Ways to Revive your Spirit: 5 quotes to Inspire You
This blog post is shared through Tigerlily Foundation’s partnership with CTCA. What does it really mean to revive? Simply put, it means “to make something operative or valid again.” So […]
Brain Metastasis Research: A Summary of Two Recent Reviews
Many types of cancer are capable of spreading or metastasizing to the brain including lung, breast, melanoma and colorectal cancer. There is no cure for metastatic cancer of any type, […]
Cascadian Therapeutics Announces Positive Regulatory Update for Tucatinib in Europe EMA Confirms Single HER2CLIMB Trial, If Positive, Could Support Approval
SEATTLE, July 11, 2017 – Cascadian Therapeutics, Inc. (NASDAQ:CASC), a clinical-stage biopharmaceutical company, today announced the outcome of discussions with the European Medicines Agency (EMA) regarding the development of tucatinib, an […]